Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Adamopoulos

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
International Journal of Cancer|August 16, 2014
Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancerAntonios N Gargalionis, Penelope Korkolopoulou, Elena Farmaki, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
BMC Cancer|March 3, 2016
Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosisStratigoula Sakellariou, Paraskevi Fragkou, Georgia Levidou, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
Scientific Reports|February 20, 2016
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcomeEleftheria Lakiotaki, Georgia Levidou, Maria K Angelopoulou, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
International Journal of Cancer|August 16, 2014
Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancerAntonios N Gargalionis, Penelope Korkolopoulou, Elena Farmaki, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
BMC Cancer|March 3, 2016
Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosisStratigoula Sakellariou, Paraskevi Fragkou, Georgia Levidou, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
Scientific Reports|February 20, 2016
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcomeEleftheria Lakiotaki, Georgia Levidou, Maria K Angelopoulou, et al.
Pageof 7